Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A

The common cause of parotid fistula is parotid gland surgery and is frequently due to injury to the gland rather than to the duct. The frequency of postparotidectomy fistula is 14%. Other causes include facial trauma, congenital anomalies of the parotid gland, malignancies originating from the parot...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Ripon, Roy, Dev, Roy, Abhimanyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191560/
https://www.ncbi.nlm.nih.gov/pubmed/34188411
http://dx.doi.org/10.4103/njms.NJMS_72_20
_version_ 1783705891137126400
author Chowdhury, Ripon
Roy, Dev
Roy, Abhimanyu
author_facet Chowdhury, Ripon
Roy, Dev
Roy, Abhimanyu
author_sort Chowdhury, Ripon
collection PubMed
description The common cause of parotid fistula is parotid gland surgery and is frequently due to injury to the gland rather than to the duct. The frequency of postparotidectomy fistula is 14%. Other causes include facial trauma, congenital anomalies of the parotid gland, malignancies originating from the parotid gland and infections. Although there are several options for the treatment of parotid fistula and Frey's syndrome, very few treatment options are deemed optimal. The use of Botulinum A neurotoxin as a conservative method of treatment for parotid fistula and Frey's syndrome is a recent and evolving concept.
format Online
Article
Text
id pubmed-8191560
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-81915602021-06-28 Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A Chowdhury, Ripon Roy, Dev Roy, Abhimanyu Natl J Maxillofac Surg Case Report The common cause of parotid fistula is parotid gland surgery and is frequently due to injury to the gland rather than to the duct. The frequency of postparotidectomy fistula is 14%. Other causes include facial trauma, congenital anomalies of the parotid gland, malignancies originating from the parotid gland and infections. Although there are several options for the treatment of parotid fistula and Frey's syndrome, very few treatment options are deemed optimal. The use of Botulinum A neurotoxin as a conservative method of treatment for parotid fistula and Frey's syndrome is a recent and evolving concept. Wolters Kluwer - Medknow 2021 2021-03-16 /pmc/articles/PMC8191560/ /pubmed/34188411 http://dx.doi.org/10.4103/njms.NJMS_72_20 Text en Copyright: © 2021 National Journal of Maxillofacial Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Chowdhury, Ripon
Roy, Dev
Roy, Abhimanyu
Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A
title Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A
title_full Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A
title_fullStr Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A
title_full_unstemmed Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A
title_short Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A
title_sort management of parotid fistula and frey's syndrome with botulinum neurotoxin type a
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191560/
https://www.ncbi.nlm.nih.gov/pubmed/34188411
http://dx.doi.org/10.4103/njms.NJMS_72_20
work_keys_str_mv AT chowdhuryripon managementofparotidfistulaandfreyssyndromewithbotulinumneurotoxintypea
AT roydev managementofparotidfistulaandfreyssyndromewithbotulinumneurotoxintypea
AT royabhimanyu managementofparotidfistulaandfreyssyndromewithbotulinumneurotoxintypea

Ejemplares similares